Cristin Hubbard

CIK: 0002021836

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (37.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BMRN

BIOMARIN PHARMACEUTICAL INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
May 20, 2026
Tax Payment(F)
Direct
2.3K shares at avg. $50.20$116K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $56.05$70K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 16, 2026
Award(A)
Direct
15.4K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Oct 31, 2025
Award(A)
Direct
80 shares at avg. $45.53$4K
BMRN
BIOMARIN PHARMACEUTICAL INC
May 20, 2025
Tax Payment(F)
Direct
2.2K shares at avg. $59.93$129K
BMRN
BIOMARIN PHARMACEUTICAL INC
May 2, 2025
Sale(S)
Direct
273 shares at avg. $64.92$18K
BMRN
BIOMARIN PHARMACEUTICAL INC
Apr 30, 2025
Award(A)
Direct
273 shares at avg. $54.14$15K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2025
Award(A)
Direct
13.3K shares-

		Type	Shares	Price		Ownership
May 20, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	2,318	$50.20	$116,364	Direct
Mar 17, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	1,245	$56.05	$69,782	Direct
Mar 16, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	15,410	-	$0	Direct
Oct 31, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	80	$45.53	$3,643	Direct
May 20, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	2,155	$59.93	$129,149	Direct
May 2, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Sale(S)	273	$64.92	$17,723	Direct
Apr 30, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	273	$54.14	$14,779	Direct
Mar 17, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	13,310	-	-	Direct

1-8 of 8 transactions

About Hubbard Cristin

Hubbard Cristin (SEC CIK 0002021836) files insider reports with the SEC as EVP, Chief Commercial Officer of BIOMARIN PHARMACEUTICAL INC (BMRN).

Signal8 holds 6 ownership filings by Hubbard Cristin (5 Form 4, 1 Form 5), filed between Mar 18, 2025 and May 21, 2026. Those filings report 8 transactions, from Mar 17, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hubbard Cristin's filings is in SAN RAFAEL, CA.

Recent filings by Hubbard Cristin

May 20, 2026: Tax withholding of BMRN shares (Form 4, code F).
Mar 17, 2026: Tax withholding of BMRN shares (Form 4, code F).
Mar 16, 2026: Grant or award of BMRN shares (Form 4, code A).
Oct 31, 2025: Grant or award of BMRN shares (Form 5, code A).
May 20, 2025: Tax withholding of BMRN shares (Form 4, code F).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R, EVP, Chief R&D Officer
Plenge Robert M, Director
Davis George Eric, EVP, Chief Legal Officer
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director

How to read Form 4 transaction codes